Evaluating the analgesic effect and advantage of transcutaneous electrical acupoint stimulation for moderate to severe cancer-related pain in hepatocellular carcinoma
Phase 1
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- ITMCTR2100004628
- Lead Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Participants match the diagnostic criteria for hepatocellular cancer established by the Union for International Cancer Control (UICC) [21];
2.A numerical rating scale (NRS) score 4;
3.Aged 50-80years (either sex);
4.A Karnofsy performance state scale (KPS) score >= 60;
5.Patients have the ability to estimate themselves;
6.Able to understand the nature of the study and willing to give informed consent;
7.Written informed consent.
Exclusion Criteria
1.Other physiological or pathological causes of pain;
2.Resection surgery performed within the last 3–6 months;
3.Serious acute or chronic organic diseases or psychiatric disorders;
4.Pregnancy or currently lactating;
5.Patients with skin lesions in local acupoints.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Brief Pain Inventory;numerical rating scale;dosage and administration duration of opioid drugs;
- Secondary Outcome Measures
Name Time Method Brief Fatigue Inventory ;the Karnofsky Performance Status Scale ;Pittsburgh sleep quality index;